Recent Updates
Recently added Catalysts
INSP Positive Sentiment Score: 75/100

Inspire Medical Systems, Inc. to Present at the BofA Securities 2026 Healthcare Conference

Wednesday, April 29, 2026 1 min read
Key Takeaway: Inspire Medical Systems, Inc. will present at the BofA Securities 2026 Healthcare Conference on May 13, 2026. The presentation will be available via a live webcast, with a replay accessible for two weeks afterward. Inspire specializes in minimally invasive solutions for obstructive sleep apnea, with its Inspire therapy being FDA approved.

Market Sentiment Analysis

POSITIVE FACTORS

  • Inspire Medical Systems is presenting at a major healthcare conference.
  • The company focuses on innovative solutions for obstructive sleep apnea.
  • Inspire therapy is FDA and EU MDR approved.

Full Press Release Details

MINNEAPOLIS, April 29, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the BofA Securities 2026 Healthcare Conference on Wednesday, May 13, 2026.
Inspire is scheduled to present at 11:00 a.m. Eastern Time. The presentation will be accessible via a live webcasthere.
A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website athttps://investors.inspiresleep.com.
About Inspire Medical SystemsInspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visitwww.inspiresleep.com.

Investor and Media ContactEzgi YagciVice President, Investor Relationsezgiyagci@inspiresleep.com617-549-2443

Frequently Asked Questions

When will Inspire Medical Systems present at the conference?

Inspire Medical Systems will present on May 13, 2026, at 11:00 a.m. ET.

How can I access the presentation?

The presentation will be available via a live webcast on Inspire's website.

What technology does Inspire Medical Systems focus on?

Inspire focuses on innovative, minimally invasive solutions for obstructive sleep apnea.

Is Inspire therapy approved by regulatory bodies?

Yes, Inspire therapy is FDA and EU MDR approved.

Tags: INSP Viatris Investor Conferences Healthcare Inspire Medical Systems obstructive sleep apnea BofA Securities healthcare conference
Last updated: Apr 29, 2026